Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumiracoxib dose regimen study in knee OA
NCT00366938Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2003
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lumiracoxib in osteoarthritis (OA), sponsored by Novartis. Started Sep 2003; status: completed.
02
Drugs
lumiracoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00366938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366938.